Progyny, Inc. Files 8-K Report

TL;DR

Progyny filed an 8-K, looks like routine corporate stuff, no major news.

AI Summary

On September 18, 2024, Progyny, Inc. filed an 8-K report. The filing indicates no specific material events or changes requiring immediate disclosure under the standard 8-K items. It appears to be a routine filing or an update related to ongoing corporate matters.

Why It Matters

This filing is a standard regulatory disclosure by Progyny, Inc. to the SEC, providing transparency to investors about the company's corporate activities.

Risk Assessment

Risk Level: low — The filing is a standard 8-K report and does not disclose any new material risks or adverse events.

Key Numbers

• 001-39100 — SEC File Number (Identifies Progyny's filing with the SEC.)
• 27-2220139 — IRS Employer Identification No. (Company's tax identification number.)

Key Players & Entities

• Progyny, Inc. (company) — Registrant
• Auxogyn, Inc. (company) — Former company name
• Delaware (jurisdiction) — State of incorporation
• New York (location) — Principal executive office city

FAQ

Key Financial Figures

• $0.0001 — nge on which registered Common Stock , $0.0001 par value per share PGNY The Nasdaq Gl

Filing Documents

• pgny-20240918.htm (8-K) — 30KB
• 0001551306-24-000183.txt ( ) — 151KB
• pgny-20240918.xsd (EX-101.SCH) — 2KB
• pgny-20240918_lab.xml (EX-101.LAB) — 21KB
• pgny-20240918_pre.xml (EX-101.PRE) — 12KB
• pgny-20240918_htm.xml (XML) — 3KB

01 Other Events

Item 8.01 Other Events. Progyny, Inc. (the "Company") was recently notified by a significant client (the "Client") that the Client has elected to exercise a 90-day option to terminate its services agreement with the Company, effective as of January 1, 2025. The Client confirmed that they had no issues of concern over the course of its multi-year relationship with the Company, including member satisfaction or quality of service or outcomes. There have not been any disputes with the Client during the course of service. As the existing agreement remains in effect for the remainder of this calendar year, the termination of these services is not expected to have an adverse impact on the Company's financial results for its fiscal year ending December 31, 2024. The Client, which represents approximately 670,000 members as of June 30, 2024, comprised 12% and 13% of the Company's revenue for the six-month period ending June 30, 2024, and the twelve-month period ending December 31, 2023, respectively. The Client comprises a smaller percentage of the Company's Adjusted EBITDA and no other existing client comprises more than a single digit percentage of revenue or Adjusted EBITDA. The Company continues to anticipate an increase in its overall member count in 2025 as compared to 2024. The Company remains disciplined in managing its business and is well-positioned to continue on its established path of achieving growth, profitability and cash flow by seeking to ensure that members are getting the right care at the right time as they realize their dreams of family building and ideal health.

Forward-Looking Statements

Forward-Looking Statements This report contains forward-looking statements, including, without limitation, statements regarding financial outlook, including the impact of the sales season and client launches; anticipated number of clients and covered lives; expected utilization rates and average revenue per utilizing member; the demand for solutions; expectations for the selling season for 2025 launches; positioning to successfully manage economic uncertainty on the business; the timing of client decisions; ability to retain existing clients and acquire new clients; and business strategy, plans, goals and expectations concerning market position, future operations, and other financial and operating information. The words "anticipates," "assumes," "believe," "contemplate," "continues, " "could," "estimates," "expects," "future," "intends," "may," "plans," "predict," "potential," "project," "seeks," "should," "target," "will," and the negative of these or similar expressions and phrases are intended to identify forward-looking statements, though not all forward-looking statements use these words or expressions. Forward-looking statements are neither promises nor guarantees, but involve known and unknown risks, uncertainties and other important factors that may cause actual results, performance or achievements to be materially different from any future results, performance or achievements expressed or implied by the forward-looking statements. For a detailed discussion of factors that could cause actual results to differ materially from these forward-looking statements, please refer to the Company's filings with the Securities and Exchange Commission (the "SEC"), including in the section entitled "Risk Factors" in the Company's Annual Report on Form 10-K for the fiscal year ended December 31, 2023, and subsequent reports that the Company files with the SEC. Forward-looking statements represent management's beliefs and assumptions only as of the date of this report. Ac

01 Financial Statements and Exhibits

Item 9.01 Financial Statements and Exhibits. (d) Exhibits Exhibit No. Description 104 Cover Page Interactive Data File (embedded within the Inline XBRL document)

SIGNATURES

SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Progyny, Inc. Dated: September 18, 2024 By: /s/ Peter Anevski Peter Anevski Chief Executive Officer

View Full Filing

View this 8-K filing on SEC EDGAR